Intracerebroventricular opioids for intractable pain

British Journal of Clinical Pharmacology

Volumn 74, Issue 1, 2012, Pages 34-41

  Raffa, Robert B ^a   Pergolizzi, Joseph V ^b,c,d  

^a TEMPLE UNIVERSITY   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Analgesia; Intracerebroventricular; Ommaya; Opioids; Palliative and hospice care; Refractory pain

Indexed keywords

BETA ENDORPHIN; MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 GLUCURONIDE; OPIATE; PROLACTIN;

ANALGESIA; ARTICLE; CANCER PAIN; CONSTIPATION; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; DRUG TOLERABILITY; DRUG TOLERANCE; DRUG TRANSPORT; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOTHERMIA; INTRACTABLE PAIN; LATENT PERIOD; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RESPIRATION DEPRESSION; SIDE EFFECT; SPINAL CORD;

ANALGESICS, OPIOID; HUMANS; INJECTIONS, INTRAVENTRICULAR; PAIN, INTRACTABLE; PALLIATIVE CARE; SEVERITY OF ILLNESS INDEX;

EID: 84862115330     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2012.04201.x     Document Type: Article

References (70)

1. Portenoy RK. Treatment of cancer pain. Lancet 2011; 377: 2236-47.
2. Adolph MD, Stretanski MF, McGregor JM, Rawn BL, Ross PM, Benedetti C. Intracerebroventricular morphine for refractory cancer pain: transitioning to the home setting. Am J Hosp Palliat Care 2010; 27: 326-32.
3. Ommaya AK. Subcutaneous reservoir and pump for sterile access to ventricular cerebrospinal fluid. Lancet 1963; 282: 983-4.
4. Ommaya AK, Rubin RC, Henderson ES, Rall DP, Gieseke FG, Bering EA Jr, Bagan M. A new approach to the treatment of inoperable brain tumors. Med Ann Dist Columbia 1965; 34: 455-8.
5. Witorsch P, Williams TW Jr, Ommaya AK, Utz JP. Intraventricular administration of amphotericin B. Use of subcutaneous reservoir in four patients with mycotic meningitis. JAMA 1965; 194: 699-702.
6. Hosobuchi Y, Li CH. The analgesic activity of human beta-endorphin in man (1, 2, 3). Commun Psychopharmacol 1978; 2: 33-7.
7. Catlin DH, Hui KK, Loh HH, Li CH. Advances in Biochemical Psychopharmacology. New York: Raven Press, 1978.
8. Foley KM, Inturrisi CE, Kourides IA, Kaiko RF, Posner JB, Houde RW, Li CH. Characteristics and Function of Opioids. Amsterdam, The Netherlands: Elsevier/North-Holland, 1978.
9. Leavens ME, Hill CS Jr, Cech DA, Weyland JB, Weston JS. Intrathecal and intraventricular morphine for pain in cancer patients: initial study. J Neurosurg 1982; 56: 241-5.
10. Roquefeuil B, Benezech J, Batier C, Marchal J. Analgesia by intraventricular injection of morphine. Agressologie 1982; 23: 119-22.
11. Roquefeuil B, Blanchet P, Batier C, Benezech J. Intraventricular morphine analgesia. Apropos of 4 cases, 1 with self-administration. Ann Fr Anesth Reanim 1982; 1: 649-54.
12. Lobato RD, Madrid JL, Fatela LV, Rivas JJ, Reig E, Lamas E. Intraventricular morphine for control of pain in terminal cancer patients. J Neurosurg 1983; 59: 627-33.
13. Roquefeuil B, Benezech J, Batier C, Blanchet P, Gros C, Mathieu-Daude JC. Value of intraventricular morphine analgesia in intractable neoplasm pain. Apropos of 8 cases with self-administration in 4. Neurochirurgie 1983; 29: 135-41.
14. Roquefeuil B, Benezech J, Blanchet P, Batier C, Frerebeau P, Gros C. Intraventricular administration of morphine in patients with neoplastic intractable pain. Surg Neurol 1984; 21: 155-8.
15. Lobato RD, Madrid JL, Fatela LV, Sarabia R, Rivas JJ, Gozalo A. Intraventricular morphine for intractable cancer pain: rationale, methods, clinical results. Acta Anaesthesiol Scand Suppl 1987; 85: 68-74.
16. Pawl RP. Intraventricular morphine. Neurosurgery 1986; 18: 250-1.
17. Ballantyne JC, Carwood CM. Comparative efficacy of epidural, subarachnoid, and intracerebroventricular opioids in patients with pain due to cancer. Cochrane Database Syst Rev 2005; (1): CD005178.
18. Blond S, Dubar M, Meynadier J, Combelles-Pruvot M, Vitrac P. Cerebral Intraventricular Administration of Morphine in Cancer Patients with Intractable Pain. Utrecht, The Netherlands: VNU Science Press, 1985.
19. Blond S, Meynadier J, Brichard C, Guieu JD, Willer JC, Le Bars D. Intra-cerebro-ventricular mophinotherapy (ICVM) (n = 79) and study of the supraspinal action of morphine (M). Pain 1987; 30: (Suppl. 1): S391.
20. Dennis GC, DeWitty RL. Long-term intraventricular infusion of morphine for intractable pain in cancer of the head and neck. Neurosurgery 1990; 26: 404-7; discussion 407-8.
21. Esposito S, Delitala A. Transoval administration of opiates into trigeminal cistern for cancer pain. Preliminary report. Neurochirurgia (Stuttg) 1991; 34: 116-8.
22. Houdek M, Opavsky J, Ostrizek J. Intracerebroventricular application of morphine in the treatment of intractable malignant pain. Acta Univ Palacki Olomuc Fac Med 1990; 128: 101-6.
23. Karavelis A, Foroglou G, Selviaridis P, Fountzilas G. Intraventricular administration of morphine for control of intractable cancer pain in 90 patients. Neurosurgery 1996; 39: 57-61; discussion 61-2.
24. Lenzi A, Galli G, Gandolfini M, Marini G. Intraventricular morphine in paraneoplastic painful syndrome of the cervicofacial region: experience in thirty-eight cases. Neurosurgery 1985; 17: 6-11.
25. Lobato RD, Madrid JL, Fatela LV, Gozalo A, Rivas JJ, Sarabia R. Analgesia elicited by low dose intraventricular morphine in terminal cancer patients. Adv Pain Res Ther 1985; 9: 673-81.
26. Nurchi G. Use of intraventricular and intrathecal morphine in intractable pain associated with cancer. Neurosurgery 1984; 15: 801-3.
27. Obbens EA, Hill CS, Leavens ME, Ruthenbeck SS, Otis F. Intraventricular morphine administration for control of chronic cancer pain. Pain 1987; 28: 61-8.
28. Reeve WG, Todd JG. Intraventricular diamorphine via an Ommaya shunt for intractable cancer pain. Br J Anaesth 1990; 65: 544-7.
29. Cramond T, Stuart G. Intraventricular morphine for intractable pain of advanced cancer. J Pain Symptom Manage 1993; 8: 465-73.
30. Smith KA, Frank E. Stereotaxic placement of a ventricular catheter and reservoir for the administration of morphine sulfate. Axone 1991; 13: 12-5.
31. Opavsky J, Houdek M. Administration of morphine into the cerebral ventricles in chronic intractable pain. Cesk Neurol Neurochir 1990; 53: 264-8 (English Abstract).
32. Lee TL, Kumar A, Baratham G. Intraventricular morphine for intractable craniofacial pain. Singapore Med J 1990; 31: 273-6.
33. Carlisle DW, Smith KA, Frank E, Meyers FJ. Intraventricular morphine administered by hospice nurses to a patient with intractable pain. Am J Hosp Care 1989; 6: 36-9.
34. Caputi CA, Busca G, Fogliardi A, Rychlicki F, Basili P. Epidural and intraventricular morphine therapy in the treatment of cancer pain. Minerva Anestesiol 1986; 52: 351-5.
35. Ballantyne JC, Carr DB, Berkey CS, Chalmers TC, Mosteller F. Comparative efficacy of epidural, subarachnoid, and intracerebroventricular opioids in patients with pain due to cancer. Reg Anesth 1996; 21: 542-56.
36. Vojkovic SJ, Kristjanson LJ. Case study report of two palliative care patients receiving intracerebroventricular (ICV) analgesia. J Palliat Care 2003; 19: 280-3.
37. Serrié A. Analgesic effect of morphine and its metabolites administered by an intracerebroventricular route. Bulletin 1995; 179: 1237-52; discussion 1252-3.
38. Lazorthes YR, Sallerin BA, Verdie JC. Intracerebroventricular administration of morphine for control of irreducible cancer pain. Neurosurgery 1995; 37: 422-8; discussion 428-9.
39. Seiwald M, Alesch F, Kofler A. Intraventricular morphine administration as a treatment possibility for patients with intractable pain. Wien Klin Wochenschr 1996; 108: 5-8.
40. Weigl K, Mundinger F, Chrubasik J. Continuous intraventricular morphine- or peptide-infusion for intractable cancer pain. Acta Neurochir Suppl (Wien) 1987; 39: 163-5.
41. Tafani JA, Lazorthes Y, Danet B, Verdie JC, Esquerre JP, Simon J, Guiraud R. Human brain and spinal cord scan after intracerebroventricular administration of iodine-123 morphine. Int J Rad Appl Instrum B 1989; 16: 505-9.
42. Akaike A, Shibata T, Satoh M, Takagi H. Analgesia induced by microinjection of morphine into, and electrical stimulation of, the nucleus reticularis paragigantocellularis of rat medulla oblongata. Neuropharmacology 1978; 17: 775-8.
43. Dickenson AH, Oliveras JL, Besson JM. Role of the nucleus raphe magnus in opiate analgesia as studied by the microinjection technique in the rat. Brain Res 1979; 170: 95-111.
44. Tsou K, Jang CS. Studies on the Site of Analgesic Action of Morphine by Intracerebral Micro-Injection. Sci Sin 1964; 13: 1099-109.
45. Yaksh TL, Rudy TA. Narcotic analgestics: CNS sites and mechanisms of action as revealed by intracerebral injection techniques. Pain 1978; 4: 299-359.
46. Yeung JC, Rudy TA. Multiplicative interaction between narcotic agonisms expressed at spinal and supraspinal sites of antinociceptive action as revealed by concurrent intrathecal and intracerebroventricular injections of morphine. J Pharmacol Exp Ther 1980; 215: 633-42.
47. Sandouk P, Serrie A, Urtizberea M, Debray M, Got P, Scherrmann JM. Morphine pharmacokinetics and pain assessment after intracerebroventricular administration in patients with terminal cancer. Clin Pharmacol Ther 1991; 49: 442-8.
48. Bull JWD. The Robert Wartenberg Memorial Lecture: the volume of the cerebral ventricles. Neurology 1961; 11: 1-9.
49. Smith MT, Wright AW, Williams BE, Stuart G, Cramond T. Cerebrospinal fluid and plasma concentrations of morphine, morphine-3-glucuronide, and morphine-6-glucuronide in patients before and after initiation of intracerebroventricular morphine for cancer pain management. Anesth Analg 1999; 88: 109-16.
50. Milne RW, Nation RL, Somogyi AA. The disposition of morphine and its 3- and 6-glucuronide metabolites in humans and animals, and the importance of the metabolites to the pharmacological effects of morphine. Drug Metab Rev 1996; 28: 345-472.
51. Sjogren P, Jonsson T, Jensen NH, Drenck NE, Jensen TS. Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine. Pain 1993; 55: 93-7.
52. Smith MT, Watt JA, Cramond T. Morphine-3-glucuronide - a potent antagonist of morphine analgesia. Life Sci 1990; 47: 579-85.
53. Gong QL, Hedner J, Bjorkman R, Hedner T. Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat. Pain 1992; 48: 249-55.
54. Faura CC, Olaso MJ, Garcia Cabanes C, Horga JF. Lack of morphine-6-glucuronide antinociception after morphine treatment. Is morphine-3-glucuronide involved? Pain 1996; 65: 25-30.
55. Cramond T. Invasive Techniques for Neuropathic Pain. New York: Oxford University Press, 1998.
56. Sutters KA, Miaskowski C, Taiwo YO, Levine JD. Analgesic synergy and improved motor function produced by combinations of mu-delta- and mu-kappa-opioids. Brain Res 1990; 530: 290-4.
57. Sandouk P, Serrie A, Scherrmann JM, Langlade A, Bourre JM. Presence of morphine metabolites in human cerebrospinal fluid after intracerebroventricular administration of morphine. Eur J Drug Metab Pharmacokinet 1991; 3: 166-71.
58. Goudas LC, Langlade A, Serrie A, Matson W, Milbury P, Thurel C, Sandouk P, Carr DB. Acute decreases in cerebrospinal fluid glutathione levels after intracerebroventricular morphine for cancer pain. Anesth Analg 1999; 89: 1209-15.
59. Lee M, Silverman SM, Hansen H, Patel VB, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician 2011; 14: 145-61.
60. Langlade A, Serrie A, Sandouk P, Thurel C, Cunin G. Levels of morphine and metabolites in CSF during respiratory depression after intraventricular morphine injection. Pain 1991; 44: 175-8.
61. Gong QL, Hedner T, Hedner J, Bjorkman R, Nordberg G. Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide. Eur J Pharmacol 1991; 193: 47-56.
62. Pelligrino DA, Riegler FX, Albrecht RF. Ventilatory effects of fourth cerebroventricular infusions of morphine-6- or morphine-3-glucuronide in the awake dog. Anesthesiology 1989; 71: 936-40.
63. Paul D, Standifer KM, Inturrisi CE, Pasternak GW. Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite. J Pharmacol Exp Ther 1989; 251: 477-83.
64. Tallarida RJ, Porreca F, Cowan A. Statistical analysis of drug-drug and site-site interactions with isobolograms. Life Sci 1989; 45: 947-61.
65. Su CF, Liu MY, Lin MT. Intraventricular morphine produces pain relief, hypothermia, hyperglycaemia and increased prolactin and growth hormone levels in patients with cancer pain. J Neurol 1987; 235: 105-8.
66. Kronenberg MF, Laimer I, Rifici C, Saltuari L, Bramanti P, Moriggl U, Norer B, Kofler A. Epileptic seizure associated with intracerebroventricular and intrathecal morphine bolus. Pain 1998; 75: 383-7.
67. Goudas LC, Carr DB, Maszczynska I, Marchand JE, Wurm WH, Greenblatt DJ, Kream RM. Differential effect of central versus parenteral administration of morphine sulfate on regional concentrations of reduced glutathione in rat brain. Pharmacology 1997; 54: 92-7.
68. National Hospice and Palliative Care Organization. NHPCO Facts and Figures: Hospice Care in America, 2010 ed. Alexandria, VA: National Hospital and Palliative Care Organization, 2010.
69. Parsells Kelly J, Cook SF, Kaufman DW, Anderson T, Rosenberg L, Mitchell AA. Prevalence and characteristics of opioid use in the US adult population. Pain 2008; 138: 507-13.
70. Gan TJ, Ginsberg B, Glass PS, Fortney J, Jhaveri R, Perno R. Opioid-sparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate. Anesthesiology 1997; 87: 1075-81.